IPOs and Secondaries

IPOs and Secondaries Articles

Bellicum Pharmaceuticals shares pulled back on Tuesday after the firm announced that it would be conducting a secondary offering to raise some cash.
Dropbox has seen the quiet period for its underwriters following the initial public offering come to an end, and the analysts have issued a wide range of price targets and mixed ratings.
China's first-quarter GDP grows rapidly, Netflix posts incredibly strong earnings, Tesla to pause Model 3 production, and other important headlines.
Smartsheet intends to price more than 11 million shares in a range that results in an initial public offering valued up to more than $160 million.
Eight IPOs on the coming week's calendar are seeking to raise more than $2.6 billion in capital.
Zuora entered the market with a bang on Thursday. It actually entered the market at $20 per share, easily notching a 40% gain off the bat.
First Caribbean International Bank expects to price its more than 9 million shares for an initial public offering valued up to $276 million.
Now analysts are chiming in with ratings and price targets now that the Zscaler quiet period has ended.
Surface Oncology intends to price 6 million shares to result in an initial public offering valued up to more than $103 million.
The two IPOs on this week's calendar include one tech unicorn and a biotech working on a treatment from Alzheimer disease.
Goosehead Insurance has filed with the SEC regarding its initial public offering.
AT&T spin-off Vrio expects to price more than 29 million shares in a range that results in an initial public offering valued up to about $751 million.
24/7 Wall St. has tracked numerous analyst calls going into and shortly after the Spotify initial public offering.
CBS makes a below-market bid for Viacom, some executives from large technology companies urge more gun control, and other important headlines.
Spotify stock has absolutely exploded in the market, confirming practically all the bullish analysts ahead of the offering.